ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 575 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR New Drug Regimen Cures More Children with Aggressive B-Cell Lymphoma July 1, 2020 Trastuzumab Deruxtecan Plus Pertuzumab Reduce a Risk of Progression or Death... November 3, 2025 EMA Recommends Extension of Indications for Tislelizumab July 24, 2025 Popular Fitness Instructor Encourages Others to Maintain Routine Check Ups After... February 9, 2021 Load more HOT NEWS Experimental Drug Prevents Doxorubicin from Harming the Heart First Mature Estimation of Median OS for Selpercatinib in Patients with... EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma Benefit of Adjuvant Capecitabine After Curative Resection of Biliary Tract Cancer...
